SMS Pharmaceuticals Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA125120
EBIT10288
Earning Per Share77
Expenses442406
Net Profit6168
Net Profit Margin1113
Operating Profit Margin2223
Profit Before Tax9169
Dividends Per Share00
Operation Revenue567525

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of SMS Pharmaceuticals is 120 as of 3/4/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212023
Operating Activities3250409022
Investing Activities-17-35-43-152-30
Financing Activities-15-13-292-32
Others00000
Net Cash Flow02-531-39

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20203,068.45104.04-2,948.82223.67
2018312.42-884.38502.63-69.33
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of SMS Pharmaceuticals is 22 as of 3/4/2024